Cardinal Capital Management Inc (North Carolina)’s Halozyme HALO Stock Holding History

Cardinal Capital Management Inc (North Carolina)’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.2M	Buy	28,076 +7,527	+37%	+$513K	0.27%	104
2026 Q1	$1.33M	Buy	20,549 +1,860	+10%	+$131K	0.17%	120
2025 Q4	$1.26M	Buy	18,689 +921	+5%	+$62K	0.17%	123
2025 Q3	$1.3M	Buy	+17,768	New	+$1.18M	0.18%	119

Other funds holding HALO

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

MMC

Mizuho Markets Cayman Grand Cayman, Cayman Islands $2.67B AUM 103.47% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Cardinal Capital Management Inc (North Carolina)'s HALO Position: Q2 2026 in Review

Cardinal Capital Management Inc (North Carolina) increased its Halozyme (HALO) stake by 37% in Q2 2026, buying an estimated $513K and bringing the position to 28,076 shares worth $2.2M. The position accounts for 0.27% of the portfolio, ranked #104.

Cardinal Capital Management Inc (North Carolina) first reported a position in HALO in Q3 2025 and has held it in 4 quarters since. 311 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

Cardinal Capital Management Inc (North Carolina) held 28,076 shares of Halozyme worth $2.2M as of Q2 2026.
Cardinal Capital Management Inc (North Carolina) bought 7,527 Halozyme shares in Q2 2026, an estimated $513K.
Halozyme made up 0.27% of Cardinal Capital Management Inc (North Carolina)'s portfolio in Q2 2026, its #104 holding.
Cardinal Capital Management Inc (North Carolina) first reported a position in Halozyme in Q3 2025 and has held it in 4 quarters since.
311 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Cardinal Capital Management Inc (North Carolina)'s 13F filing for Q2 2026, filed 21 Jul 2026.